SU212 News

Latest Articles

• OHSU Researchers Engineer SU212 Molecule to Disrupt Enzyme Pathways in Aggressive Triple-Negative Breast Cancer

  Published: Mar 11, 2026

  Section: Science & Tech

  Scientists at Oregon Health & Science University have developed a novel compound, SU212, designed to target the ENO1 enzyme relied upon by aggressive breast cancer cells. In humani...